¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sleep activation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • delayed sleep phase syndrome
    ¼ö¸éÀ§»óÁö¿¬ÁõÈıº
  • delta sleep
    µ¨Å¸¼ö¸é
  • excessive sleep inertia
    °úµµ¼ö¸é¹«·ÂÁõ
  • electric sleep
    Àü±âÀ¯µµ¼ö¸é, Àü±â¼ö¸é
  • induced sleep
    À¯µµ¼ö¸é
  • multiple sleep latency test
    ¼ö¸éÀẹ±â¹Ýº¹°Ë»ç
  • natural sleep
    ÀÚ¿¬¼ö¸é
  • NREM sleep
    ºñ±Þ¼Ó¾È±¸¿îµ¿¼ö¸é
  • orthodox sleep
    Á¤»ó¼ö¸é
  • obstructive sleep apnea
    Æó¼â¼ö¸é¹«È£Èí
  • obstructive sleep apnea syndrome
    Æó¼â¼ö¸é¹«È£ÈíÁõÈıº
  • prolonged sleep
    Áö¼Ó¼ö¸é
  • paradoxical sleep
    ¿ª¼³¼ö¸é
  • paroxysmal sleep
    ¹ßÀÛ¼ö¸é
  • REM sleep
    ºü¸¥´«¿îµ¿¼ö¸é, ±Þ¼Ó¾È±¸¿îµ¿¼ö¸é, ·½¼ö¸é
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sleep attack
    ¼ö¸é¹ßÀÛ
  • sleep-related sinus arrest
    ¼ö¸é°ü·Ã½ÉÀå¹Úµ¿Á¤Áö
  • breathing related sleep disorder
    È£Èí°ü·Ã¼ö¸éÀå¾Ö
  • sleep bruxism
    À̰¥ÀÌ
  • circadian rhythm sleep disorder
    ÀÏÁÖ±âÀ²µ¿¼ö¸éÀå¾Ö, ÇÏ·çÁÖ±â¼ö¸éÀå¾Ö
  • crescendo sleep
    Á¡Áõ¼º¼ö¸é
  • delayed sleep phase
    Áö¿¬¼ö¸éÀ§»ó
  • delayed sleep phase syndrome
    ¼ö¸éÀ§»óÁö¿¬ÁõÈıº
  • delta sleep
    µ¨Å¸¼ö¸é
  • sleep disorder
    ¼ö¸éÀå¾Ö, ¼ö¸éº´
  • sleep drunkenness
    Àá¿¡ÃëÇÑ»óÅÂ
  • sleep-wake schedule disorder
    ¼ö¸é°¢¼ºÀÏÁ¤Àå¾Ö
  • sleep-wake transition disorder
    ¼ö¸é°¢¼ºÀÌÇàÀå¾Ö
  • electric sleep
    Àü±âÀ¯µµ¼ö¸é
  • excessive sleep inertia
    °úµµ¼ö¸é¹«·ÂÁõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • OSAS=obstructive sleep apnea syndrome
    Æó¼â¼º ¼ö¸é ¹«È£Èí ÁõÈıº
  • PLMS.see periodic limb movements during sleep
    ¼ö¸éÁß ÁÖ±âÀû »çÁö¿îµ¿
  • REM sleep behavior disorder
    ·½¼ö¸éÇൿÀå¾Ö(º´)
  • REM-sleep-promoting area
    ·½¼ö¸éÁõÁø¿µ¿ª
  • REM-sleep-related sinus arrest
    ·½¼ö¸é °ü·Ã ½ÉÀ嵿°áÀý(Ô×Ì¿ï½) Á¤Áö
  • adjustment sleep disorder
    ÀûÀÀ¼º ¼ö¸éÀå¾Ö(º´), ¼ö¸é Á¶Á¤ Àå¾Ö(º´)
  • advanced sleep phase syndrome
    ÀüÁø¼º ¼ö¸éÀ§»ó ÁõÈıº
  • hibernation =winter sleep
    µ¿¸é(ËÄËÎ), ¿ùµ¿(ËôËÄ), µ¿¸é¸¶Ãë, Àúü¿Â¹ý (ËøÌ§ËíËÑ).
  • hypnobatia =sleep walking
    ¸ùÀ¯(Áõ)(ÙÓë´ñø)
  • induced sleep
    À¯µµ¼ö¸é(¡­â²Øù).
  • induced sleep
    À¯µµ¼ö¸é(ë¯Óôâ²Øù)
  • infant sleep apnea
    ¿µ¾Æ ¼ö¸é ¹«È£ÈíÁõ
  • phase-delayed sleep
    »óÁö¿¬¼ö¸é(ßÓòÀæÅâ²Øù)
  • primary sleep disorder
    ÀÏÂ÷¼º¡¡¼ö¸éÀå¾Ö(º´)
  • prolonged sleep
    Áö¼Ó¼ö¸é(ò¥áÙâ²Øù).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • energy of activation
    Ȱ¼ºÈ­¿¡³ÊÁö.
  • heat of activation
    Ȱ¼ºÈ­¿­(üÀàõûýæð)
  • islet-activation factor
    ¶û°Ô¸£Çѽº»ù Ȱ¼ºÀÎÀÚ, ¹éÀÏÇØ±Õµ¶¼Ò
  • macrophage,activation of
    Ȱ¼ºÈ­(üÀàõûù)
  • neutron activation analysis
    Áß¼ºÀÚ¹æ»çÈ­ºÐ¼®(~Û¯ÞÒûùÝÂà°).
  • photochemical activation
    ±¤È°¼ºÈ­(Ë´Ì· ËÛÌ´).
  • plasmin activation inhibitor
    Çö󽺹ÎȰ¼ºÈ­¾ïÁ¦Á¦(¡­üÀàõûùåäð¤ð¥)
  • polyclonal B cell activation
    B¼¼Æ÷ ´Ù(¼ö)Ŭ·ÐȰ¼º, B¼¼Æ÷ ¿©·¯¹«¸®È°¼º
  • polyclonal activation
    ´Ù(¼ö)Ŭ·ÐȰ¼º, ¿©·¯¹«¸®È°¼º
  • thermal activation
    ¿­È°¼ºÈ­¹ÝÀÀ(æðüÀàõûù Úãëë).
  • tissue plasminogen activation
    Á¶Á÷ ÇöóÁî¹Ì°Õ Ȱ¼º
  • tissue plasminogen activation inhibitor
    Á¶Á÷ ÇöóÁî¹Ì³ë°Õ Ȱ¼º ¾ïÁ¦ÀÎÀÚ
  • trypsinogen activation peptide(TAP)
  • ventricular activation
    ½É½ÇÈïºÐ(ãýãøýéÝÇ).
  • ventricular activation
    ½É½ÇÈïºÐ(ãýãøýéÝÇ)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • upstream activation sites
    À­ÂÊ È°¼ºÈ­(üÀàõûù)ÀÚ¸®
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AE above-elbow [amputation]; acrodermatitis enteropathica; activation energy; adult erythrocyte; advers...
ARAM antigen recognition activation motif
CMNA complement-mediated neutrophil activation
HIPA heparin-induced platelet activation
INAA instrumental neutron activation analysis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AT Activation time
Ea Energy of activation
FAP Fibroblast Activation Protein
HIPA Heparin-induced platelet activation
GAS IFN-gamma activation site
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • obstructive sleep apnea
    Æó¼â¼º ¹«È£Èí
  • paradoxical sleep
    ¿ª¼³ ¼ö¸é
  • paroxysmal sleep
    ¹ßÀÛ¼º ¼ö¸é
  • poor quality of sleep
    ¼ö¸é ºÒ·®
  • rapid eye movement sleep
    ½Å¼Ó ¾È±¸¿îµ¿ ¼ö¸é, REM ¼ö¸é
    ½É¹Úµ¿, È£Èí ¼ö, Ç÷¾ÐÀÇ ½ÉÇÑ Áõ°¡, ±×¸®°í ºü¸¥ ¾È±¸ ¿îµ¿ ±â°£, ±Ù¿¬Ãà
  • sleep apnea
    ¼ö¸é ¹«È£ÈíÁõ, ¼ö¸é ¹«È£Èí
    ¼ö¸é Áß¿¡ ÀϾ´Â È£Èí ÀÌ»óÀ¸·Î¼­ È£Èí ´É·üÀÇ ºÎÁ·À¸·Î ÀÌÂ÷ÀûÀ¸·Î °ø±âÀÇ È帧ÀÌ ÁߴܵǴ °ÍÀÌ Æ¯Â¡ÀÌ´Ù. º¸Åë »ó±âµµ Æó¼â¿Í °ü·ÃµÇÁö¸¸ ÁßÃß¼º ¿øÀΰú °ü·ÃµÉ ¼ö ÀÖ´Ù.
  • sleep assessment
    ¼ö¸é Æò°¡
  • sleep deprivation
    ¼ö¸é ¹ÚÅ»
  • sleep disturbance
    ¼ö¸é Àå¾Ö
    ¼ö¸éÀÌ ¾çÀû, ÁúÀû ¿äÀÎÀ¸·Î Àå¾Ö¸¦ ¹Þ´Â °Í. ÃÖ±Ù ±¹Á¦Àû ºÐ·ù¿¡¼­´Â ¼ö¸é °¢¼º Àå¾Ö¶ó°í ÇÑ´Ù. ¼ö¸é Àå¾Ö´Â ºÒ¸éÁõ, °ú¸éÁõ, ¼ö¸é °¢¼º ½Ã°£
  • sleep disturbances
    ¼ö¸é Àå¾Ö
  • sleep laboratory
    ¼ö¸é °Ë»ç
  • sleep phase advance
    ¼ö¸é À§»ó ÀüÁø
  • sleep resistance
    Àá ÅõÁ¤
  • sleep terror disorder
    ¾ß°æ Àå¾Ö
    ÀáµéÀÚ °ð Àá¿¡¼­ ±ú¾î³ª °­ÇÑ ºÒ¾È°ú ÀÚÀ²½Å°æ °èÅëÀÇ Áõ»óµéÀÌ ³ªÅ¸³ª ¾Æ¹«¸® ÁøÁ¤½ÃŰ·Á ÇØµµ Àß µèÁö ¾Ê´Â »óŰ¡ µÇÇ®ÀÌÇÏ¿© ÀϾ´Â °Í.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
trans-activation (genetics) Increased rate of gene expression directed by either viral or cellular proteins. These regulatory factors (diffusible gene products) act in trans -- that is, act on homologous or heterologous molecules of DNA. (cis-acting factors act only on homologous molecules.)
(12 Dec 1998)
energy of activation Energy that must be added to that already possessed by a molecule or molecules in order to initiate a reaction; usually expressed in the Arrhenius equation relating a rate constant to absolute temperature.
(05 Mar 2000)
enzyme activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1) activation by ions (activators); 2) activation by cofactors (coenzymes); and 3) conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme.
(12 Dec 1998)
juxtacrine activation Activation of target cells by membrane anchored growth factors, also used for activation of leucocytes by PAF bound to endothelial cell surface.
(18 Nov 1997)
feedback activation The activation of an enzyme by an end product of a biochemical pathway in which that enzyme plays a part. For example, the activation of factors VIII and V by thrombin during blood clotting.
(05 Mar 2000)
feed-forward activation The activation of an enzyme by a precursor of the substrate of that enzyme.
(05 Mar 2000)
upstream activation site A DNA sequence that regulates transcription like an enhancer but does notwork if its located downstream from a promoter.
(09 Oct 1997)
low-activation materials <radiobiology> In fission reactors, one is forced to deal with the radioactive byproducts of the fission process, but in fusion reactors one generally has a choice of what materials to expose to neutrons produced by the fusion process. A major problem for fusion reactors is developing materials (such as for the reactor vacuum vessel structure) which can be exposed to high levels of neutron bombardment without becoming permanently radioactive. Candidate structural materials which have relatively low induced radiactivation (generally relative to stainless steel) are known as low-activation materials, these include titanium, vanadium, and silicon-carbide.
(09 Oct 1997)
lymphocyte activation <haematology> The change in morphology and behaviour of lymphocytes exposed to a mitogen or to an antigen to which they have been primed. The result is the production of lymphoblasts, cells that are actively engaged in protein synthesis and that divide to form effector populations. Should not be confused with transformation of the type associated with oncogenic viruses and activation is therefore perhaps a better term.
(18 Nov 1997)
rapid eye movement sleep REM sleep, that state of deep sleep in which rapid eye movements, alert EEG pattern, and dreaming occur; several central and autonomic functions are distinctive during this state.
(05 Mar 2000)
paradoxical sleep A deep sleep, with a brain wave pattern more like that of waking states than of other states of sleep, which occurs during rapid eye movement sleep.
(05 Mar 2000)
paroxysmal sleep <neurology> A disorder of sleep associated with excessive daytime sleepiness, involuntary daytime sleep episodes, disturbed nocturnal sleep and cataplexy.
Narcolepsy affects over 100,000 people in the United States and appears to have a genetic basis.
Symptoms usually begin in the patients twenties. Treatment often includes the use of amphetamines and-or tricyclic antidepressants.
(27 Sep 1997)
REM stage sleep <physiology> A stage of deep sleep that is accompanied by rapid eye movement and muscle paralysis. Vivid dreams can be recalled in over 80% of patients who awake from REM stage sleep.
(27 Sep 1997)
central sleep apnoea <neurology> A form of sleep apnoea which from the lack of neurologic stimulation to breathe.
(12 Jan 1998)
mixed sleep apnoea <chest medicine> A form of sleep apnoea where there is exists a combination of obstructive and central sleep apnoea syndromes.
(13 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á